“…Although human studies consistently found normalized CBV values after the end of stimulation (Blockley et al, 2009;Frahm et al, 2008;Jasdzewski et al, 2003;Lu et al, 2004;Poser and Norris, 2007;Schroeter et al, 2006;Toronov et al, 2003;Tuunanen et al, 2006), several animal experiments reported elevated CBV during the BOLD undershoot (Jones et al, 2001(Jones et al, , 2002Kida et al, 2007;Kim et al, 2007;Leite et al, 2002;Mandeville et al, 1998Mandeville et al, , 1999a. One possible reason for these discrepancies is a methodological difference as most of the animal studies are based on blood-pool contrast agents with iron oxide particles (Jin and Kim, 2008;Kennan et al, 1998;Kida et al, 2007;Kim et al, 2007;Mandeville et al, 1998Mandeville et al, , 1999aSmirnakis et al, 2007). Thus, to investigate the impact of the specific contrast agent used for assessing CBV effects, we set up an experiment using dynamic T1-weighted three-dimensional (3D) MRI and the blood-pool contrast agent Vasovist, containing gadofosveset trisodium (Majos et al, 2009;Morton et al, 2006).…”